Replies to post #68927 on Regen BioPharma Inc (RGBP)

[TAKURI]

$RGBP / $RGBPP !$!$!$!$!$!$!$

The global Indoleamine 2,3 Dioxygenase 1 market is categorized by the following manufacturers:

BirchBioMed Inc

Bristol-Myers Squibb Company

Ensemble Therapeutics Corp

F. Hoffmann-La Roche Ltd

Genentech Inc

Globavir Biosciences Inc

Incyte Corp

IO Biotech ApS

Kyowa Hakko Kirin

Netherlands Translational Research Center BV

NewLink Genetics Corp

Pfizer Inc

Redx Pharma Plc

Regen BioPharma Inc

https://www.mccourier.com/global-indoleamine-23-dioxygenase-1-market-2021-2026-research-covers-top-players-as-birchbiomed-inc-bristol-myers-squibb-company/